4-(Azetidin-3-yl)benzonitrile hydrochloride
95%
- Product Code: 138702
CAS:
94268-29-8
Molecular Weight: | 194.66 g./mol | Molecular Formula: | C₁₀H₁₁ClN₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, Inert Gas |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme targets, making it valuable in drug discovery. Commonly employed in research settings to design molecules with improved metabolic stability and bioavailability. Also utilized in the preparation of neuroprotective agents and compounds targeting central nervous system disorders due to its ability to cross the blood-brain barrier.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿11,410.00 |
+
-
|
250mg | 10-20 days | ฿19,390.00 |
+
-
|
1g | 10-20 days | ฿43,230.00 |
+
-
|
4-(Azetidin-3-yl)benzonitrile hydrochloride
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme targets, making it valuable in drug discovery. Commonly employed in research settings to design molecules with improved metabolic stability and bioavailability. Also utilized in the preparation of neuroprotective agents and compounds targeting central nervous system disorders due to its ability to cross the blood-brain barrier.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :